Axicabtagene-ciloleucelLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1943卷 / 1期

关键词：

D O I：

10.1007/s40278-023-33027-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：142 / 142

相关论文

共 50 条

[21] Axicabtagene-ciloleucelCytokine release syndrome: case report
Reactions Weekly, 2024, 2033 (1) : 53 - 53
[22] Axicabtagene-ciloleucel/nivolumabLack of efficacy: 7 case reports
Reactions Weekly, 2023, 1974 (1) : 68 - 68
[23] Axicabtagene ciloleucelPancytopenia, cytokine release syndrome and neurotoxicity: case report
Reactions Weekly, 2020, 1794 (1) : 40 - 40
[24] Axicabtagene-ciloleucelCytokine release syndrome and cardiotoxicity: case report
Reactions Weekly, 2024, 2023 (1) : 61 - 61
[25] Axicabtagene-ciloleucelSevere cutaneous adverse event : case report
Reactions Weekly, 2024, 2021 (1) : 95 - 95
[26] Axicabtagene-ciloleucelAdductor laryngeal breathing dystonia: case report
Reactions Weekly, 2021, 1850 (1) : 66 - 66
[27] Axicabtagene ciloleucelCytokine release syndrome and neurotoxicity: 2 case report
Reactions Weekly, 2019, 1780 (1) : 56 - 56
[28] Axicabtagene ciloleucel/doxorubicinCardiomyopathy and cytokine release syndrome: case report
Reactions Weekly, 2020, 1830 (1) : 73 - 73
[29] Axicabtagene-ciloleucelCytokine release syndrome and myocarditis: case report
Reactions Weekly, 2023, 1955 (1) : 77 - 77
[30] Axicabtagene-ciloleucel/tisagenlecleucelVarious toxicities and lack of efficacy: 12 case reports
Reactions Weekly, 2024, 2035 (1) : 93 - 93

← 1 2 3 4 5 →